Henry Schein, Inc. is the largest distributor of healthcare products and services to office-based healthcare practitioners in the combined North American and European markets. The company conducts its business principally through two segments; healthcare distribution and technology. These segments, which are operated as individual business units, offer different products and services, albeit to the same customer base. The healthcare distribution segment consists of the company's dental, medical, veterinary and international groups.
Industry sector: Medical
Sector classification: Medical & hospital equipment
Deep Learning based analysis and prediction model for Henry Schein, Inc. (HSIC) stock is a 1st Generation Non-linear Autoregresive with exogenous variable(s) (NARX) model based on the Recurrent Neural Network architecture.
Model is in the production pipeline since Oct. 2, 2015.
Market data for HSIC model training are being downloaded from the Quandl premium datasets on a daily basis.
Model is being retrained on a daily basis.
|% Held by Insiders||1.19%|
|% Held by Institutions||45.90%|
|EPS (last reported FY)||$3.31|
|EPS (last reported Q)||$0.88|
|EPS, estimated (last reported Q)||$0.87|
|Total revenues||$12 B|
|Net income||$1 B|